BI
WST icon

Binnacle Investments’s West Pharmaceutical WST Stock Holding History

Binnacle Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$262 Buy
+1
New +$243 ﹤0.01% 904

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Binnacle Investments's WST Position: Q3 2025 in Review

Binnacle Investments opened a new position in West Pharmaceutical (WST) in Q3 2025: 1 share worth $262. The stake represents ﹤0.01% of the portfolio and ranks #904 among its holdings.

756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Binnacle Investments held 1 share of West Pharmaceutical worth $262 as of Q3 2025.
  • West Pharmaceutical was a new Binnacle Investments position in Q3 2025.
  • West Pharmaceutical made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #904 holding.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.